Breaching barriers.
Kraehenbuhl
J P
JP
Swiss Institute for Cancer Research, Epalinges, Switzerland.
Wain-Hobson
S
S
D000818:Animals; D003713:Dendritic Cells / Q000187:drug effects / Q000276:immunology*; D004198:Disease Susceptibility; D004343:Drug Implants; D004848:Epithelium / Q000187:drug effects / Q000276:immunology; D005260:Female; D015658:HIV Infections / Q000276:immunology / Q000635:transmission / Q000821:virology; D006801:Humans; D008183:Luteal Phase; D008253:Macaca mulatta; D051379:Mice; D009092:Mucous Membrane / Q000187:drug effects / Q000276:immunology; D011374:Progesterone / Q000008:administration & dosage / Q000494:pharmacology*; D016097:Simian Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000635:transmission*; D015302:Simian Immunodeficiency Virus / Q000276:immunology / Q000502:physiology*; D014621:Vagina / Q000187:drug effects / Q000276:immunology* / Q000821:virology; D014766:Viremia / Q000276:immunology
D004343:Drug Implants; D011374:Progesterone